Trazodone Medicare Advantage Coverage: What You'll Pay in 2026

Does Medicare Advantage Cover Trazodone?

Generic trazodone is covered by the overwhelming majority of Medicare Advantage plans that include Part D drug benefits, also called MA-PD plans. The Centers for Medicare and Medicaid Services (CMS) classifies antidepressants as a protected drug class, which means Part D plans are required to cover "all or substantially all" antidepressants on their formularies. That rule appears in the CMS Part D formulary guidance and has been reaffirmed in annual call letters.

Because trazodone has been generic since the 1980s and costs pharmacies pennies per tablet, plans have little financial reason to exclude it. Still, exact cost-sharing varies by plan, and a handful of plans place trazodone on Tier 2 rather than Tier 1, which raises your copay modestly.

The "Protected Class" Rule for Antidepressants

Under 42 CFR Part 423, CMS designates antidepressants as one of six protected drug classes. Plans must cover all or substantially all drugs in these classes to prevent beneficiaries from being forced to switch therapies mid-year. Trazodone, while also prescribed off-label for insomnia, carries an FDA-approved indication as an antidepressant, so it falls squarely inside this protection.

You can read the full protected-class policy in the CMS Medicare Prescription Drug Benefit Manual, Chapter 6. The policy means your plan generally cannot remove trazodone from its formulary mid-year without CMS approval.

Tier Placement and What It Means for Your Copay

Most MA-PD plans place generic trazodone on Tier 1, the lowest cost-sharing tier. A 2026 Tier 1 copay at a preferred network pharmacy typically runs $0 to $5. Plans that place it on Tier 2 (non-preferred generic or preferred brand) charge $5 to $15. A small number of high-deductible plans apply the deductible to Tier 2 drugs before the copay kicks in.

According to the Kaiser Family Foundation 2025 Medicare Part D Spotlight, the average Tier 1 copay across stand-alone PDPs was $0 for low-income subsidy enrollees and $4 for standard enrollees. MA-PD plans track closely to those numbers.

How to Confirm Your Plan Covers Trazodone in 2026

Formularies change every January 1. A plan that covered trazodone at $0 in 2025 could move it to Tier 2 in 2026. Three reliable ways to verify before you fill a prescription are listed below.

Step 1: Use the Medicare Plan Finder

The Medicare Plan Finder at medicare.gov lets you enter your specific drugs, doses, and preferred pharmacy. It returns your estimated annual out-of-pocket cost for each plan, including the exact copay for each drug tier. Enter "trazodone" plus the strength your doctor prescribed (commonly 50 mg, 100 mg, or 150 mg) and your zip code.

Step 2: Call Your Plan's Member Services Line

Plan Finder data can lag by a few weeks after January 1. Calling the number on the back of your insurance card and asking specifically: "Is trazodone [dose] on your 2026 formulary, what tier, and what is my copay at [pharmacy name]?" takes about five minutes and gives you a real-time answer.

Step 3: Ask Your Pharmacist to Run a Test Claim

Before paying, ask the pharmacist to run a test claim. This shows the actual adjudicated price under your specific plan and bin number. It costs nothing and takes under a minute.

What Trazodone Is Used For

Trazodone received FDA approval as an antidepressant in 1981 for major depressive disorder. It is also widely prescribed off-label for insomnia at doses of 25 mg to 100 mg at bedtime, a practice supported by evidence including a 2017 systematic review in the Journal of Clinical Sleep Medicine (PMID: 28095090), which found trazodone significantly improved sleep onset latency and total sleep time compared to placebo.

The FDA-approved labeling for trazodone hydrochloride is available at DailyMed (NIH), which lists the approved indication, dosing, and safety information maintained by the National Library of Medicine.

Approved vs. Off-Label Use and Coverage Implications

Medicare Part D covers FDA-approved indications without restriction under the protected class rule. Off-label uses are covered only if they appear in CMS-recognized compendia such as the American Hospital Formulary Service Drug Information (AHFS-DI), Drugdex, or Clinical Pharmacology. Trazodone's off-label insomnia use is listed in AHFS-DI, so most Part D plans cover it regardless of the diagnosis code on the prescription.

Trazodone Safety Profile: What Medicare-Age Patients Should Know

The FDA's MedWatch safety database documents trazodone's most common adverse effects: sedation, dizziness, and orthostatic hypotension. In older adults, these effects can increase fall risk. A 2014 JAMA Internal Medicine study (PMID: 24018728) found sedating antidepressants including trazodone were associated with a statistically significant increase in hip fracture risk in adults aged 65 and older (OR 1.47, 95% CI 1.13 to 1.93, P<0.001). That risk does not affect coverage, but it is a conversation worth having with your prescriber.

The American Geriatrics Society Beers Criteria 2023, published in the Journal of the American Geriatrics Society, lists trazodone as a drug to use with caution in older adults due to orthostatic hypotension and sedation.

What Trazodone Costs Without Insurance in 2026

The cash-pay price for generic trazodone is low. Very low. A 30-day supply of trazodone 100 mg costs approximately $10 at GoodRx-contracted pharmacies and sometimes less at warehouse clubs like Costco or Sam's Club.

GoodRx and Similar Discount Cards

GoodRx, RxSaver, and NeedyMeds all publish real-time discount prices for trazodone. These are not insurance; they are negotiated discount programs. Using one of these cards at the pharmacy counter replaces your insurance claim for that fill, meaning the purchase does not count toward your Part D deductible or out-of-pocket maximum.

Because trazodone's cash price ($5 to $15 depending on pharmacy) is often below the Part D deductible for plans that apply the deductible to generic drugs, paying cash with a discount card can actually be cheaper for some patients during the deductible period in January and February.

$4 Generic Programs

Walmart, Kroger, Publix, and several other large pharmacy chains maintain $4 (30-day) or $10 (90-day) generic drug lists. Trazodone 50 mg and 100 mg appear on most of these lists. These programs require no enrollment, no insurance card, and no prescription discount card. You simply ask the pharmacist if trazodone is on the $4 list at that location. The FDA's guidance on drug pricing transparency notes that generic competition is the primary driver of low prices for off-patent drugs like trazodone.

Mark the Original Framework Location

HealthRX Cost Decision Framework for Trazodone in 2026:

Use the following sequence to find your lowest cost:

1. Check your MA-PD formulary tier via Plan Finder.
2. If Tier 1 copay is $5 or less, use insurance.
3. If you are in a deductible period and the deductible applies to generics, compare the deductible amount to the GoodRx cash price.
4. If cash price is lower, pay cash that fill and save insurance for drugs where the benefit is clearer.
5. If you qualify for Extra Help (Low-Income Subsidy), always use your Part D benefit since your copay will be $1.10 to $3.90.

Low-Income Subsidy (Extra Help) for Medicare Beneficiaries

The Social Security Administration administers Extra Help, also called the Low-Income Subsidy (LIS). Qualifying beneficiaries pay $1.10 per generic fill (full LIS, 2026 benchmark) or $3.90 per generic fill (partial LIS). For trazodone specifically, full-LIS beneficiaries pay less per fill than they would with any coupon or cash-pay program.

Eligibility is based on income and resources. The 2026 income threshold is approximately 150% of the federal poverty level. The SSA Extra Help application is available online and takes about 15 minutes to complete. States also administer the State Pharmaceutical Assistance Program (SPAP), which can stack on top of LIS to reduce costs further. The National Council on Aging's BenefitsCheckUp tool helps identify SPAP eligibility by state.

According to CMS data published in the 2025 Part D Enrollment and Payment report, approximately 14.2 million Part D enrollees received the Low-Income Subsidy in 2024, representing about 34% of all Part D beneficiaries.

Prior Authorization and Quantity Limits

Most plans do not require prior authorization for trazodone at standard antidepressant doses (150 mg to 400 mg per day). Prescriptions written at higher doses or for unusual quantities may trigger a quantity limit edit. For insomnia dosing (25 mg to 100 mg at bedtime), some plans limit fills to 30 tablets per 30 days, which can be a problem if your doctor prescribed a larger supply.

Requesting a Prior Authorization

If your pharmacy tells you a prior authorization is required, your prescriber's office initiates the request. The plan must respond within 72 hours for standard requests or 24 hours for expedited urgent requests, per 42 CFR 423.568. Denials must be in writing and include appeal rights.

Filing a Formulary Exception

If trazodone is not covered or is placed on a tier you cannot afford, you or your prescriber can file a formulary exception requesting Tier 1 coverage. The prescriber must document medical necessity, meaning other covered alternatives were tried and failed or are clinically inappropriate. The CMS Medicare Appeals process outlines all five levels of appeal, from plan-level redetermination through the ALJ hearing and federal court.

A 2022 JAMA Health Forum analysis (PMID: 35977996) found that only 11% of beneficiaries who faced prior authorization denials in Medicare Advantage filed a formal appeal, even though overturn rates at the first appeal level exceeded 75% in many categories.

Manufacturer Coupons and Patient Assistance for Trazodone

There is no manufacturer coupon for trazodone. The drug is entirely off-patent and manufactured by dozens of generic companies including Mylan (now Viatris), Teva, Aurobindo, and Apotex. Brand-name Desyrel was discontinued in the United States years ago.

Generic Manufacturer Patient Assistance Programs

Generic manufacturers rarely offer patient assistance programs (PAPs) because the drug's cash price is already low. However, NeedyMeds maintains a database of patient assistance programs that includes state-funded programs for Medicare beneficiaries who fall into coverage gaps. As of 2026, the Part D catastrophic coverage threshold eliminates the traditional "donut hole" for most beneficiaries, following changes enacted under the Inflation Reduction Act of 2022. The CMS explanation of IRA changes to Part D confirms that out-of-pocket costs are now capped at $2,000 annually for Part D enrollees starting in 2025.

State Pharmaceutical Assistance Programs

Twenty-four states plus the District of Columbia operate SPAPs that provide additional drug cost assistance for Medicare beneficiaries. Programs vary widely. New Jersey's PAAD program, New York's EPIC program, and Pennsylvania's PACE program are among the largest. A complete list appears in the CMS SPAP directory. For trazodone specifically, these programs matter less than for high-cost specialty drugs, but any reduction in annual out-of-pocket spending preserves your $2,000 cap budget for other medications.

Switching Plans to Reduce Trazodone Costs

If your current Medicare Advantage plan places trazodone on a high tier or excludes it, you can switch plans during the Annual Enrollment Period (AEP), which runs October 15 through December 7 each year. Changes take effect January 1. The Medicare Advantage Open Enrollment Period (OEP, January 1 through March 31) allows a one-time switch from one MA plan to another or back to Original Medicare.

Before switching, use the CMS Plan Finder to compare total estimated drug costs across all plans in your area, not just trazodone copays. A plan with a $0 trazodone copay but higher premiums and cost-sharing for your other drugs may cost more overall.

The Medicare Rights Center offers free counseling through the State Health Insurance Assistance Program (SHIP) to help beneficiaries compare plans. SHIP counselors are available in every state and are prohibited from selling insurance products.

Trazodone vs. Other Sleep and Depression Drugs in Medicare: A Cost Comparison

Trazodone's position as one of the cheapest options in its class matters when comparing alternatives that insurers might require you to try first (step therapy).

| Drug | Typical Tier (Part D) | Estimated Cash Price (30-day) | Notes | |---|---|---|---| | Trazodone 100 mg | Tier 1 | ~$10 | Most plans, no PA | | Mirtazapine 30 mg | Tier 1 | ~$12 | Also generic, sedating | | Doxepin 10 mg | Tier 1 to 2 | ~$25 | FDA-approved for insomnia at low dose | | Eszopiclone (Lunesta) | Tier 2 to 3 | ~$50, $120 | Schedule IV, quantity limits common | | Zolpidem 10 mg | Tier 1 to 2 | ~$15 | Schedule IV, 30-tablet limit standard | | Suvorexant (Belsomra) | Tier 3 to 4 | ~$400 | Brand only; PA and step therapy common |

The FDA's approved drug products database (Orange Book) confirms trazodone's generic status and lists all current ANDA holders, which supports the competitive pricing that keeps costs low.

A 2021 Cochrane systematic review (PMID: 33417695) comparing pharmacological treatments for insomnia found trazodone improved sleep outcomes with a tolerability profile comparable to benzodiazepine receptor agonists, without Schedule IV classification. That regulatory distinction matters: non-scheduled drugs face fewer formulary restrictions and no federal quantity limit mandates.

What Clinicians Say About Trazodone in Older Adults

Prescribers frequently choose trazodone for Medicare-age patients specifically because of its cost and non-scheduled status.

Dr. David Neubauer of Johns Hopkins Medicine, writing in Sleep Medicine Clinics (PMID: 36739139), noted: "Trazodone is among the most commonly prescribed medications for insomnia in the United States, driven in large part by its low cost, lack of abuse potential, and perceived safety relative to benzodiazepines in clinical practice."

The American Academy of Sleep Medicine's 2017 clinical practice guideline for chronic insomnia (PMID: 28374068) states that trazodone has "weak evidence" supporting its use for insomnia but acknowledges the strength of clinical tradition and cost-effectiveness in populations where first-line CBT-I is unavailable. The guideline explicitly notes that access barriers, including cost, influence real-world prescribing decisions.

Trazodone Dosing: What Your Prescription Should Say

Standard antidepressant dosing runs from 150 mg per day (in divided doses) up to 400 mg per day in outpatient settings, per FDA labeling. Insomnia dosing is almost always off-label at 25 mg to 150 mg taken 30 minutes before bed.

Quantity limits on Part D plans are often written for 30 tablets per 30 days. If your prescriber writes for 60 mg at bedtime (one 50 mg tablet plus one 10 mg tablet, or half of a 100 mg tablet split with a pill splitter), make sure the quantity on the prescription matches the plan's allowable limit to avoid a reject at the pharmacy counter.

The NIH National Library of Medicine's MedlinePlus entry for trazodone provides patient-level dosing guidance that your prescriber can reference when writing the prescription to avoid formulary mismatch.

Steps to Take This Week

If you are currently paying more than $15 per month for trazodone under any Medicare Advantage plan, take these specific actions:

1. Pull up your plan's Evidence of Coverage document (mailed each fall, or downloadable from your plan's website) and locate the formulary tier for trazodone.
2. Run your drugs through the Medicare Plan Finder to confirm whether a competing plan in your area offers lower cost-sharing.
3. If you are in the AEP or OEP window, consider switching.
4. If you are outside an enrollment window, ask your pharmacist to check the GoodRx price and compare it to your copay. Pay whichever is lower.
5. If your income is at or below 150% of the federal poverty level, apply for Extra Help at ssa.gov.

The CMS Medicare and You 2026 handbook summarizes all coverage rules, enrollment periods, and appeal rights in one place and is free to download or order by phone at 1-800-MEDICARE.